Adrenochrome (PD037978, RPHLQSHHTJORHI-UHFFFAOYSA-N)
· archived 5/22/2026, 12:25:09 AMcached html General Preferred name Adrenochrome Synonyms Adraxone () P&D ID PD037978 CAS 54-06-8 Tags available Probe control Probe control not defined Orthogonal probes 0 No orthogonal probes found Similar probes 0 No structurally similar probes found Structure Probe scores P&D probe-likeness score [[ v.score ]]% [[ v.label ]] [[ v.value ]] Structure formats [[ format ]] [[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]] Description (extracted from source data) DESCRIPTION Adrenochrome (Adraxone) is an oxidation product of Epinephrine. Adrenochrome is a potent coronary constricting agent in the rat heart. Adrenochrome can be used for neurological disorder research[1][2][3]. PRICE 85 DESCRIPTION Adrenochrome (Adraxone) is a cytotoxic molecule that can be used to kill bacteria. Adrenochrome is an oxidized product of Epinephrine. Adrenochrome is a coronary systolic compound that acts on rat hearts and is associated with cardiotoxicity and can be used to determine superoxide dismutase activity. Adrenochrome is a potential psychotropic drug for the study of nervous system diseases. (TargetMol Bioactive Compound Library) [[ p.pathway_name ]] [[ p.dbid ]] [[ compound.targets[tid].gene_name ]] Compound Sets 4 Cayman Chemical Bioactives 43520 MedChem Express Bioactive Compound Library HY-116513 ReFrame library TargetMol Bioactive Compound Library T20094 [[ a.name ]] [[ ligand_id ]] free of charge External IDs 19 Properties (calculated by RDKit ) Molecular Weight 179.06 Hydrogen Bond Acceptors 4 Hydrogen Bond Donors 1 Rotatable Bonds 0 Ring Count 2 Aromatic Ring Count 0 cLogP -0.75 TPSA 57.61 Fraction CSP3 0.33 Chiral centers 1.0 Largest ring 6.0 QED 0.39 Structural alerts 2 quinone_D(2) [#6]-1(-[#6]=,:[#6]-[#6]=,:[#6]-[#6]-1=[!#6&!#1])=[!#6&!#1] PAINS Family C imine_one_A(321) [#6]-[#6](=[!#6&!#1;!R])-[#6](=[!#6&!#1;!R])-[$([#6]),$([#16](=[#8])=[#8])] PAINS Family A Related compounds Custom attributes (extracted from source data) Target Drug Metabolite antioxidant Pathway Metabolic Enzyme/Protease oxidation-reduction Source data